Back to results
US 12,631,636 B2Granted
Peptidoglycan (PGN) aptamers and associated methods
AssigneeFresenius Medical Care Holdings, Inc.
InventorTao Jiang
Life of this patent
Estimating the term…
Abstract
Described are a number of aptamers that are specific to bind with peptidoglycan (“PGN”) with specificity over counter-targets lipopolysaccharides (“LPS”) and lipoteichoic acid (“LTA”), and associated methods.
Claims22
A DNA aptamer comprising a polynucleotide comprising a core sequence set forth in any one of SEQ ID NOs:
- 11-20 and capable of binding to peptidoglycan (“PGN”).
Dependencies are inferred from the claim text.